Plan B Saga Exposes FDA To Drug-Approval Suits

Law360, New York (June 19, 2013, 6:04 PM EDT) -- The U.S. Food and Drug Administration’s losing battle against wider access to Plan B emergency contraception was widely viewed as politically motivated, and undermined its credibility in a way that could embolden pharmaceutical companies to challenge the agency when it rejects approval for other controversial products, experts say.

Most of the damage was done long before a judge this year ordered wider access, capping the second of two long-running lawsuits. While the FDA in 2011 dropped its opposition to age restrictions on the one-pill version of...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Tummino et al v. Hamburg et al


Case Number

1:12-cv-00763

Court

New York Eastern

Nature of Suit

Other Statutory Actions

Judge

Edward R. Korman

Date Filed

February 16, 2012

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.